ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 322 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $92,940,000 | +132.9% | 1,000,000 | +73.9% | 0.72% | +42.0% |
Q1 2021 | $39,900,000 | -9.7% | 575,007 | 0.0% | 0.50% | +6.5% |
Q4 2020 | $44,178,000 | -5.5% | 575,007 | -8.0% | 0.47% | -30.6% |
Q3 2020 | $46,753,000 | -32.2% | 625,129 | -42.9% | 0.68% | -38.9% |
Q2 2020 | $68,938,000 | +143.1% | 1,095,129 | +62.2% | 1.12% | +51.2% |
Q1 2020 | $28,356,000 | -34.5% | 675,129 | -29.2% | 0.74% | -14.1% |
Q4 2019 | $43,291,000 | -0.8% | 953,129 | 0.0% | 0.86% | -26.8% |
Q3 2019 | $43,624,000 | -46.1% | 953,129 | -30.9% | 1.18% | -36.7% |
Q2 2019 | $80,919,000 | +28.9% | 1,380,171 | -1.4% | 1.86% | +4.9% |
Q1 2019 | $62,770,000 | +12.9% | 1,400,171 | -2.1% | 1.77% | -16.3% |
Q4 2018 | $55,605,000 | -11.6% | 1,430,171 | +4.6% | 2.12% | +25.8% |
Q3 2018 | $62,908,000 | +71.4% | 1,366,978 | +62.4% | 1.68% | +74.8% |
Q2 2018 | $36,710,000 | +440.4% | 841,978 | +389.6% | 0.96% | +406.3% |
Q1 2018 | $6,793,000 | +809.4% | 171,978 | +682.5% | 0.19% | +660.0% |
Q4 2017 | $747,000 | – | 21,978 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 530,670 | $49,320,000 | 10.96% |
Paradigm Biocapital Advisors LP | 251,777 | $23,400,000 | 6.68% |
RAMIUS ADVISORS LLC | 161,770 | $15,035,000 | 5.27% |
First Light Asset Management, LLC | 645,848 | $60,025,000 | 4.30% |
Affinity Asset Advisors, LLC | 100,000 | $9,294,000 | 3.38% |
SECTORAL ASSET MANAGEMENT INC | 230,043 | $21,380,000 | 3.22% |
ALPINE ASSOCIATES MANAGEMENT INC. | 806,200 | $74,929,000 | 2.80% |
DAFNA Capital Management LLC | 119,615 | $11,117,000 | 2.80% |
HAVENS ADVISORS LLC | 24,500 | $2,277,000 | 2.69% |
Prosight Management, LP | 45,000 | $4,182,000 | 2.50% |